Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1997 Feb;73(856):105–107. doi: 10.1136/pgmj.73.856.105

Reversible acute renal failure induced by losartan in a renal transplant recipient.

M Ostermann 1, D J Goldsmith 1, T Doyle 1, J C Kingswood 1, P Sharpstone 1
PMCID: PMC2431233  PMID: 9122087

Abstract

A 56-year-old man who received a live-related renal transplant in 1988 was started in 1995 on the selective angiotensin II antagonist losartan (Dupont-Merke) to treat worsening hypertension. Two months later because of pulmonary oedema, loop diuretics were started. Within two weeks, serum creatinine had increased from 245 to 571 mumol/l, and the patient became oliguric. A systolic bruit was noted over the graft. Renal angiography showed a 90% stenosis of the transplant renal artery. Losartan was withdrawn, with prompt improvement in renal function. A successful percutaneous transluminal angioplasty performed a few days later resulted in further improvement in renal function accompanied by a significant diuresis.

Full text

PDF
106

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cohen L. S., Friedman E. A. Losartan-induced azotemia in a diabetic recipient of a kidney transplant. N Engl J Med. 1996 May 9;334(19):1271–1272. doi: 10.1056/NEJM199605093341915. [DOI] [PubMed] [Google Scholar]
  2. Johnston C. I. Angiotensin receptor antagonists: focus on losartan. Lancet. 1995 Nov 25;346(8987):1403–1407. doi: 10.1016/s0140-6736(95)92411-6. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES